Novartis AG (NVS), the world’s fifth-largest independent biotech company, is using a cutting-edge and cost-effective technique called ‘Combination Screening‘ to discover a constant stream of new, ground-breaking medicines.
This little-known ‘Combination Screening’ technique has now been successfully adapted to trading by European hedge fund managers, to create a constant stream of new, robust trading strategies and ideas.
Busy traders, starving for time, can now build profitable trading strategies for the Futures or Stock markets – like these actual breakout trading strategies built by Oliver from Germany using this process: